Henry Ford Health has treated the first Michigan patient outside clinical trials with Roctavian, the newly approved gene ...

The patient, who is in his 30s, got the one-time intravenous infusion at the Infusion and Chemotherapy Treatment Center at ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

The rise of gene editing forces regulators to confront a difficult question: How to protect fair play in the age of genomic medicine.

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

The difficulty is that EBV lives latently in B cells in the blood at a frequency, in most immunocompetent individuals, of about 1 in 100,000 to 1 in a million. That level of infection is below the ...

Hims & Hers Health, Inc. faces volatile earnings as compounded GLP-1 setbacks pressure shares. Click for this HIMS stock ...

In this Q&A article with the Eye Care Network, Daniela Ferrara, MD, PhD, FASRS, FARVO, discusses the role of low- and ...

New research from the University of Minnesota School of Dentistry and Masonic Cancer Center is providing important new insights into the structure of ...

The rejection of Disc Medicine Inc.’s experimental compound for a rare and devastating disorder by the US Food and Drug Administration, just months after it received a voucher intended to speed US ...

Early treatment helps with swallowing and eating for SMA kids, but new research is needed on the effects of disease-modifying ...

Gathered at the ‘Let’s Taco-Bout It’ LAHS Key Club event Feb. 9 at SALA are, from left, Emily Xu, Lilly Viteva, Sean Lo, Morrie Pongratz, Angel Meng, Jessica Strong, Adrian Koo and ...